2
Announcements
Trials
Browse
Landscape
Phase
Phase NA
2
Status
Withdrawn
1
Completed
1
Sponsor Class
OTHER
2
Study Type
Interventional
2
Sponsor
Cancer Type
Gynecologic
2
Gastrointestinal
1
Breast
1
Conditions
Breast Neoplasms
15
Colorectal Neoplasms
6
Neoplasms
4
Thyroid Neoplasms
3
Prostatic Neoplasms
3
Ovarian Neoplasms
2
Colonic Neoplasms
2
Carcinoma, Renal Cell
2
Uterine Cervical Neoplasms
1
Unmet Fertility Information Needs
1
Thyroid Cancer, Papillary
1
Smoking Cessation
1
Patient Participation
1
Papillary Thyroid Microcarcinoma
1
Pancreatic Neoplasms
1
Neuroma, Acoustic
1
Melanoma
1
Lymphoma, Follicular
1
Lung Neoplasms
1
Kidney Neoplasms
1
Heartburn
1
Healthy Volunteers
1
Gastroesophageal Reflux
1
Esophageal Neoplasms
1
Depression
1
Dementia
1
Colorectal Cancer Screening
1
Carcinoma, Medullary
1
Carcinoma, Intraductal, Noninfiltrating
1
COVID-19
1
Interventions
Paclitaxel
328
Carboplatin
323
Bevacizumab
171
Gemcitabine
106
liposomal doxorubicin
104
pembrolizumab
100
Topotecan
94
Cyclophosphamide
94
olaparib
92
Cisplatin
92
niraparib
69
Docetaxel
57
Taxes
52
Doxorubicin
51
Drug Therapy
45
fludarabine
39
Filgrastim
39
Nivolumab
37
Magnetic Resonance Spectroscopy
34
Surveys and Questionnaires
33
Specimen Handling
33
Etoposide
32
Hyperthermic Intraperitoneal Chemotherapy
31
Blood Specimen Collection
29
Immunoglobulin G
27
Disulfides
27
Peripheral Blood Stem Cell Transplantation
26
Cytoreduction Surgical Procedures
25
Albumin-Bound Paclitaxel
25
durvalumab
24
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
2 trials
Recent
Start date
Enrollment
Ovarian Neoplasms
×
Decision Support Techniques
×
Clear all
NCT05512260
2026-02-11
BESTa
Karolinska Institutet
Phase NA
Withdrawn
NCT02259699
2019-06-10
PCOA
University of California, Irvine
Phase NA
Completed
124 enrolled
11 charts